Skip to main content
Expert Insights Quiz

Choosing the Right Digital Therapeutic for MDD Treatment

Reference

Chan, S. Tapping Into Neuroplasticity Through Digital Therapeutics for MDD. Psych Congress Network. Published online February 10, 2025. Accessed March 17, 2025.

 


Steven Chan, MD, MBA, FAPA, FAMIA, is a member of Stanford Psychiatry’s TechHub Leadership Committee, faculty with the Stanford Addiction Medicine Fellowship, and a clinical educator caring for patients with substance use disorders (SUD) and addictions. Dr Chan is a clinical informaticist, addiction medicine physician, and psychiatrist. He is a clinical associate professor affiliated with the Stanford University School of Medicine, and Immediate Past Chair of the Committee on Innovation at the American Psychiatric Association. He serves on the Board of Directors at Mental Health America. Dr. Chan is a sought-after national speaker whose ideas, thoughts, and research have been featured at Google headquarters, JAMA, Telemedicine and e-Health, JMIR, Wired, PBS, and NPR Ideastream. He serves as Chief Technology Officer and co-founder of AsyncHealth — a University of California-backed digital mental health startup supported by Berkeley SkyDeck PAD-13 and the National Science Foundation Innovation Corps (NSF i-Corps) — and writes at both @stevenchanMD and @mpowerhacks.


© 2025 HMP Global. All Rights Reserved.
 
Any views and opinions expressed above are those of the author(s) and do not necessarily reflect the views, policy, or position of the Psych Congress Network or HMP Global, their employees, and affiliates.